%0 Journal Article
%T Antimicrobial Susceptibility of Multidrug-Resistant <i>Acinetobacter baumanii</i> in a Teaching Hospital: A Two-Year Observation
%A Cucunawangsih &nbsp
%A Veronica Wiwing
%A Nata Pratama Hardjo Lugito
%J Open Journal of Medical Microbiology
%P 85-89
%@ 2165-3380
%D 2015
%I Scientific Research Publishing
%R 10.4236/ojmm.2015.52010
%X Multidrug-resistant (MDR) <i>Acinetobacter baumanii</i> (<i>A. baumanii</i>) caused hospital acquired infection, typically in critical-ill patients with medical devices. This is a retrospective descriptive study on epidemiology and microbiology data to determine the antimicrobial susceptibility pattern of MDR-<i>Acinetobacter baumanii</i> isolates from a teaching hospital in Tangerang, Indonesia from Januari 2013 to December 2014. A total of 84 <i>A. baumanii</i> were collected. Patients suffering from respiratory tract infection had the highest number (41.7%) of <i>A. baumanii</i> isolate. There were 39 (46.6%) patients admitted in critical care. <i>A. baumanii</i> isolates in this study mostly were multidrug-resistant organisms with low susceptibility level to 11 antibiotic tested, 44% - 69% in 2013 and 26% - 67% in 2014. A high susceptibility level was observed to amikacin (80% and 79% in 2013, 2014 consecutively) and trimethoprim-sulfamethoxazole (73% and 72% in 2013, 2014 consecutively). <i>A. baumanii</i> is a hospital acquired pathogen in critically-ill patients. The susceptibility pattern of this study result showed MDR organism. There was a sharp decrease of susceptibility in all antibiotics studied from 2013 to 2014 except amikacin and trimethoprim-sulfamethoxazole.
%K Multidrug-Resistant &lt
%K i&gt
%K Acinetobacter baumanii&lt
%K /i&gt
%K Antimicrobial Susceptibility
%K Amikacin
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=56940